Nutex Health (NUTX): Divisadero Street Capital Management, LP opened a new position $7.48M
Divisadero Street Capital Management, LP opened a new position in Nutex Health, per its Q2 2025 13F.
- 60K
- Shares reported
- 0.48%
- Disclosed portfolio weight
- $7.48M
- Reported value
- Holdings as of
- Jun 30, 2025
- Filed
- Aug 14, 2025
What stands out in this filing
- A new position in Q2 2025: 60,094 shares, none in the manager's Q1 2025 filing.
- Reported at $7.48M, 0.48% of the portfolio value in this 13F filing.
- 1 other tracked manager reported the same kind of change for Q2 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
- Aug 22, 2025Court · District Court, S.D. TexasSecurities lawsuit filed: Bhagavan v. Nutex Health Inc.
- Sep 16, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 16, 2025 the Board of Directors (the "Board") of Nutex Health, Inc. (the "Company") appointed Mr. Wesley Bamburg to serve as the Company's Chief Operating Officer, effective on or about October 13, 2025 (the “Commencement Date”).”
- Oct 20, 2025Company filing · Form 8-K · Results, Listing noticeReceived a notice from its stock exchange, and reported its results“As previously disclosed, on August 20, 2025, the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “June 30, 2025 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is…”
- Nov 18, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 18, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 18, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 19, 2025Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Nutex Health
For Nutex Health, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NUTX page.
How this filing works
Explore the data
Common questions
What does this filing report about Nutex Health (NUTX) stock?
Divisadero Street Capital Management, LP opened a new position in Nutex Health, per its Q2 2025 13F. 60K shares reported, 0.48% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2025. Filed: Aug 14, 2025.
What stands out in this filing?
A new position in Q2 2025: 60,094 shares, none in the manager's Q1 2025 filing. Reported at $7.48M, 0.48% of the portfolio value in this 13F filing. 1 other tracked manager reported the same kind of change for Q2 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Nutex Health recently?
For Nutex Health, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the NUTX page.
Does this mean NUTX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Nutex Health
Everything OQRO holds on this company is on its NUTX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
